Style | Citing Format |
---|---|
MLA | Hendijani F, Haghjooy Javanmard S, Sadeghialiabadi H. "Human Wharton's Jelly Mesenchymal Stem Cell Secretome Display Antiproliferative Effect on Leukemia Cell Line and Produce Additive Cytotoxic Effect in Combination With Doxorubicin." Tissue and Cell, vol. 47, no. 3, 2015, pp. 229-234. |
APA | Hendijani F, Haghjooy Javanmard S, Sadeghialiabadi H (2015). Human Wharton's Jelly Mesenchymal Stem Cell Secretome Display Antiproliferative Effect on Leukemia Cell Line and Produce Additive Cytotoxic Effect in Combination With Doxorubicin. Tissue and Cell, 47(3), 229-234. |
Chicago | Hendijani F, Haghjooy Javanmard S, Sadeghialiabadi H. "Human Wharton's Jelly Mesenchymal Stem Cell Secretome Display Antiproliferative Effect on Leukemia Cell Line and Produce Additive Cytotoxic Effect in Combination With Doxorubicin." Tissue and Cell 47, no. 3 (2015): 229-234. |
Harvard | Hendijani F, Haghjooy Javanmard S, Sadeghialiabadi H (2015) 'Human Wharton's Jelly Mesenchymal Stem Cell Secretome Display Antiproliferative Effect on Leukemia Cell Line and Produce Additive Cytotoxic Effect in Combination With Doxorubicin', Tissue and Cell, 47(3), pp. 229-234. |
Vancouver | Hendijani F, Haghjooy Javanmard S, Sadeghialiabadi H. Human Wharton's Jelly Mesenchymal Stem Cell Secretome Display Antiproliferative Effect on Leukemia Cell Line and Produce Additive Cytotoxic Effect in Combination With Doxorubicin. Tissue and Cell. 2015;47(3):229-234. |
BibTex | @article{ author = {Hendijani F and Haghjooy Javanmard S and Sadeghialiabadi H}, title = {Human Wharton's Jelly Mesenchymal Stem Cell Secretome Display Antiproliferative Effect on Leukemia Cell Line and Produce Additive Cytotoxic Effect in Combination With Doxorubicin}, journal = {Tissue and Cell}, volume = {47}, number = {3}, pages = {229-234}, year = {2015} } |
RIS | TY - JOUR AU - Hendijani F AU - Haghjooy Javanmard S AU - Sadeghialiabadi H TI - Human Wharton's Jelly Mesenchymal Stem Cell Secretome Display Antiproliferative Effect on Leukemia Cell Line and Produce Additive Cytotoxic Effect in Combination With Doxorubicin JO - Tissue and Cell VL - 47 IS - 3 SP - 229 EP - 234 PY - 2015 ER - |